Davina J H, Stadhouders A M, van Haelst U J, Lamers G E, Kenemans P
Gynecol Oncol. 1985 Oct;22(2):212-23. doi: 10.1016/0090-8258(85)90029-0.
The lectin binding capacity of the cell surface of normal flattened exfoliated epithelial cells of the uterine cervix was investigated looking for differences between specimens from normal and cancer patients. The method used was a modified concanavalin A-horseradish peroxidase (Con A-HRP) labeling procedure. Both normal and cancer specimens contain labeled as well as unlabeled usual flattened cells. There is a distinct difference between the labeling intensity of labeled and that of unlabeled cells. Quantification of the labeling results has been achieved using a light microscope equipped with a computerized video system. Apparently healthy persons, having a percentage of labeled flattened cells between 54 and 94% (mean = 73%, SD = 10%, N = 40), were totally discriminated by this method from the cancer patients. These patients with a histologically confirmed squamous cell carcinoma, showed a labeling percentage between 10 and 22% (mean = 15%, SD = 4%, N = 10). Hormonal factors, such as phase of cycle and pill use, appeared to have no significant influence. Statistical analysis revealed that at least 99% of all healthy persons will have a labeling percentage above 45%, while at most 1% of the cancer patients will show a labeling percentage above 30%. When choosing the labeling percentage of 45% as critical value, the Con A-HRP labeling might serve as an additional detection method for cancer of the uterine cervix. Moreover, as it is based on the abundantly present normal cells, and not on the often scarce abnormal cells, the method is not liable to sampling and screening errors.
研究了子宫颈正常扁平脱落上皮细胞表面的凝集素结合能力,以寻找正常标本与癌症患者标本之间的差异。所采用的方法是改良的伴刀豆球蛋白A-辣根过氧化物酶(Con A-HRP)标记程序。正常标本和癌症标本中均含有标记和未标记的常见扁平细胞。标记细胞和未标记细胞的标记强度存在明显差异。使用配备计算机视频系统的光学显微镜对标记结果进行了量化。通过这种方法,标记扁平细胞百分比在54%至94%之间(平均值=73%,标准差=10%,N=40)的明显健康人被完全与癌症患者区分开来。这些经组织学确诊为鳞状细胞癌的患者,标记百分比在10%至22%之间(平均值=15%,标准差=4%,N=10)。激素因素,如月经周期阶段和避孕药使用情况,似乎没有显著影响。统计分析表明,所有健康人中至少99%的标记百分比将高于45%,而癌症患者中最多1%的标记百分比将高于30%。当选择45%的标记百分比作为临界值时,Con A-HRP标记可作为子宫颈癌的一种额外检测方法。此外,由于该方法基于大量存在的正常细胞,而非通常稀少的异常细胞,因此该方法不易出现采样和筛查误差。